연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2024년 | 2023년 | 2022년 | 2021년 | 2020년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 179편 | 173편 | 163편 | 184편 | 135편 |
| 공동 | 147편 | 120편 | 115편 | 136편 | 168편 | |
| 합계 | 326편 | 293편 | 278편 | 320편 | 303편 | |
3347. Development of Indocyanine Green/Methyl-β-cyclodextrin Complex-Loaded Liposomes for Enhanced Photothermal Cancer Therapy
MinKyu Kim, Jee-Eun Hwang, Jeong-Seob Lee, Jiwoo Park, Chiwoo Oh, Subin Lee, Jiyeon Yu, Wang Zhang, Hyung-Jun Im
ACS APPLIED MATERIALS & INTERFACES, 2024 Jul 3;16(26):32945-32956
Link
3346. A Spatial Transcriptomics Based Label-Free Method for Assessment of Human Stem Cell Distribution and Effects in a Mouse Model of Lung Fibrosis
Jeongbin Park, Dongjoo Lee, Jae Eun Lee, Daeseung Lee, In Ho Song, Hyun Soo Park, Hongyoon Choi,Hyung-Jun Im
Advanced Therapeutics. 2024 January 24;7(4):1-13
3345. Immune marker expression and prognosis of early breast cancer expressing HER3
Lee DW, Ryu HS, Nikas IP, Koh J, Kim TY, Kim HK, Lee HB, Moon HG, Han W, Lee KH, Im SA
European journal of cancer (Oxford, England : 1990) 2024 Dec:213:115081.
Link
3344. Harnessing Institutionally Developed Clinical Targeted Sequencing to Improve Patient Survival in Breast Cancer: A Seven-Year Experience
Koh J, Kim J, Woo GU, Yi H, Kwon SY, Seo J, Bae JM, Kim JH, Won JK, Ryu HS, Jeon YK, Lee DW, Kim M, Kim TY, Lee KH, Kim TY, Lee JS, Seong MW, Kim S, Lee S, Yun H, Song MG, Choi J, Kim JI, Im SA
Cancer research and treatment 2024 Aug 21 [Epub ahead of print]
Link
3343. Tracing the evolutionary history of breast cancer
Koh J, Im SA
Nature reviews. Cancer 2024 Oct;24(10):653.
Link
3342. Results from the randomized KEYNOTE-355 study of pembrolizumab plus chemotherapy for Asian patients with advanced TNBC
Im SA, Cortes J, Cescon DW, Yusof MM, Iwata H, Masuda N, Takano T, Huang CS, Chung CF, Tsugawa K, Park YH, Matsumoto K, Inoue K, Kwong A, Loi S, Fu W, Pan W, Karantza V, Rugo HS, Schmid P
NPJ breast cancer 2024 Sep 12;10(1):79
Link
3341. The DNA repair pathway as a therapeutic target to synergize with trastuzumab deruxtecan in HER2-targeted antibody-drug conjugate-resistant HER2-overexpressing breast cancer
Lee J, Kida K, Koh J, Liu H, Manyam GC, Gi YJ, Rampa DR, Multani AS, Wang J, Jayachandran G, Lee DW, Reuben JM, Sahin A, Huo L, Tripathy D, Im SA, Ueno NT
Journal of experimental & clinical cancer research : CR 2024 Aug 21;43(1):236.
Link
3340. Clinicopathological analysis of claudin 18.2 focusing on intratumoral heterogeneity and survival in patients with metastatic or unresectable gastric cancer
Kim TY, Kwak Y, Nam SK, Han D, Oh DY, Im SA, Lee HS
ESMO Open. 2024 Dec;9(12):104000
Link
3339. Prognostic significance of CD8 and TCF1 double positive T cell subset in microsatellite unstable gastric cancer
Park J, Nam SK, Kwak Y, Oh HJ, Kong SH, Park DJ, Lee HJ, Yang HK, Lee HS
Sci Rep. 2024 Nov 21;14(1):28810
Link
3338. Clinicopathologic Characteristics of Trop Family Proteins (Trop-2 and EpCAM) in Gastric Carcinoma
Kim HS, Kim Y, Lee HS
J Gastric Cancer. 2024 Oct;24(4):391-405
Link